PMID: 39212900 Retatrutide purchased from MedChemExpress
A Guide to Weight-Loss Medications: Anti-obesity drugs, from older pills to the new GLP-1s Losing weight is hard to do
As captured July 2026, compounded semaglutide runs about $299/mo ongoing and compounded tirzepatide about $399/mo ongoing, flat across dose, with prepaid bundles available
Data points represent the mean of at least three independent experiments
NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP-1 Weight Loss Drugs Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 Washington, DC A year ago, the National Consumers League took the unusual step of flagging warnings from the Food and Drug Administration (FDA) and medical societies stating that compounded versions of GLP-1 (glucagon-like peptide-1 receptor agonists) weight-loss drugs are not FDA approved and may cause serious health problems
We monitor your progress and provide guidance on the crucial lifestyle factorsnutrition, hydration, activitythat work in synergy with the medication
